Topic: COVID-19 vaccine development

The Short Report – Dec. 22, 2021: Trudeau releases mandate letters, a promising brain diseases partnership, a national survey of young people’s attitudes towards science, and more

A new Quebec neuroscience partnership may advance drug discovery for brain diseases through AI and Open Science; a CFI national survey shows most young adults have confidence in science; Dr. Leah Cowen has been named the University of Toronto’s vice-president, research and innovation, and strategic initiatives, and more.

The Short Report – April 28, 2021: COVID-19 data portal goes live, Protein Industries Canada launches new phase of plant-based food plan, Carleton funding bolsters ecosystem conservation, and more

Genome Canada’s portal for tracking variants of concern across Canada is up and running; a Carleton biology team gets support for bolstering ecosystem conservation; Protein Industries Canada starts the second phase of plans to boost plant-based foods, feed and ingredients; a briefing from the Royal Society of Canada calls on federal leadership to stabilize the postsecondary sector; and more.

Feds invest $887 million to ensure reliable vaccine supply for COVID-19, other pandemics

The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.